Related Experiment Video

Updated: Jun 21, 2026

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection
08:16

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection

Published on: July 21, 2022

Caspase inhibitors for the treatment of hepatitis C

Howard C Masuoka1, Maria Eugenia Guicciardi, Gregory J Gores

  • 1Division of Gastroenterology and Hepatology, Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Clinics in Liver Disease
|July 25, 2009
PubMed

Insights

Caspase inhibitors show promise in reducing liver injury and fibrosis by decreasing hepatocyte apoptosis in hepatitis C. Further long-term studies are needed to confirm their therapeutic potential for patients.

Area of Science:

  • Hepatology
  • Cellular Biology
  • Pharmacology

Background:

  • Hepatocyte injury and death are key targets for treating chronic hepatitis C and liver diseases.
  • Apoptotic cell death, executed by caspases, drives liver injury and hepatic fibrogenesis in hepatitis C.
  • Caspase inhibitors are being developed to reduce cellular apoptosis and protect liver cells.

Purpose of the Study:

  • To evaluate the potential of caspase inhibitors as hepatoprotective agents in liver diseases, particularly chronic hepatitis C.
  • To assess the efficacy of these agents in minimizing liver injury and fibrosis by reducing hepatocyte apoptosis.

Main Methods:

  • Administration of caspase inhibitors in animal models of liver disease.
  • Conducting time-limited studies in human patients with hepatitis C.
  • Monitoring for reduction in hepatocyte apoptosis and assessment of liver injury and fibrosis.

Main Results:

  • Animal studies and preliminary human trials suggest caspase inhibitors are promising therapeutic agents.
  • These agents have the potential to attenuate cellular apoptosis and serve as hepatoprotective agents.
  • Evidence indicates a possible role in minimizing liver injury and fibrosis.

Conclusions:

  • Caspase inhibitors demonstrate potential for treating liver diseases characterized by hepatocyte apoptosis.
  • Further long-duration studies focusing on hepatic fibrogenesis as an endpoint are crucial.
  • The therapeutic utility requires more extensive investigation before widespread clinical application in hepatitis C patients.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.